Dr. Reddy’s surges on completing USFDA audit for Srikakulam API manufacturing facility

17 Apr 2017 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 2686.00, up by 44.60 points or 1.69% from its previous closing of Rs. 2641.40 on the BSE.

The scrip opened at Rs. 2718.00 and has touched a high and low of Rs. 2721.95 and Rs. 2683.30 respectively. So far 50420 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3689.00 on 20-Jul-2016 and a 52 week low of Rs. 2560.00 on 22-Mar-2017.

Last one week high and low of the scrip stood at Rs. 2,721.95 and Rs. 2,616.05 respectively. The current market cap of the company is Rs. 44644.19 crore.

The promoters holding in the company stood at 26.79%, while Institutions and Non-Institutions held 44.46% and 12.17% respectively.

Dr. Reddy’s Laboratories’ API manufacturing plant at Srikakulam (SEZ) in state of Andhra Pradesh has completed the audit by the US Food and Drug Administration (USFDA) on April 14, 2017 with no observations.

Besides, the company is recalling 1,728 bottles of Rivastigmine Tartrate capsules, used for treatment of dementia, due to cross-contamination with other products from the US market. The company’s US arm, Dr. Reddy’s Laboratories Inc is recalling Rivastigmine Tartrate capsules 1.5 mg in 60-count bottle manufactured by the company in India.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1255.45 1.85 (0.15%)
02-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.35
Dr. Reddys Lab 1255.45
Cipla 1510.95
Zydus Lifesciences 916.50
Lupin 2105.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×